MedCompanion

Staphylococcus aureus Bacteremia

Sepsis & Nonfocal

Source: IDMP View on spectrum chart →
Patient + scenario modifiers
Patient
Clinical scenario / source

Annotations only — chart still shows the full chemistry of each drug.

1. Clinical Syndrome

≥1 blood culture growing Staphylococcus aureus (MSSA or MRSA) in an adult. S. aureus is never a contaminant — every positive blood culture must be treated. Distinct from coagulase-negative staph (often contaminant).

Excludes: CoNS bacteremia (separate workup); endocarditis with hardware (link to future endocarditis syndrome — though SAB workup must include the endocarditis pathway).

2. Pathogens

Consider the patient: IVDU, hemodialysis, indwelling line, prosthetic material (pacemaker, joint, valve), recent surgery, DM, MRSA colonization status, prior S. aureus infection.

Consider the case: Source identification (line, skin/SSTI, bone, lung, endocarditis, deep abscess), persistent vs cleared bacteremia (repeat blood cultures q48h), echocardiography (TTE then TEE if any complicated feature), evaluation for metastatic foci.

3. Empiric Therapy

TierFirst choiceAlternativesDurationComments
Admitted to ward
  • 2 g · q8h · IV · 14 days from first negative blood culture (uncomplicated MSSA)

    Drug of choice for MSSA — preferred over nafcillin (better tolerated, lower mortality in observational data, q8h vs q4h).

  • 2 g · q4h · IV · 14 days

    Use for CNS source (better penetration than cefazolin) or specific MIC concerns.

14 days (uncomplicated MSSA, line removed, no metastatic foci, no endocarditis)MSSA bacteremia, uncomplicated. **ID consult mandatory** — mortality benefit (Holland JAMA 2014, multiple cohort studies).
Admitted to ward
  • load + AUC-guided · AUC 400–600 · IV · 14 days from first negative blood culture (uncomplicated MRSA)
  • 8–10 mg/kg · q24h · IV · 14 days

    NOT for pneumonia source (surfactant inactivates). Useful if vanco MIC ≥1 or vanco failure.

14 days from first negative blood cultureMRSA bacteremia, uncomplicated. Repeat blood cultures q48h until clear.
Admitted to ICU
  • 2 g · q8h · IV

    MSSA — confirmed methicillin susceptibility.

  • load + AUC-guided · — · IV

    MRSA or empiric pre-susceptibility.

  • 10 mg/kg · q24h · IV

    MRSA persistent bacteremia (consider combo with cefazolin or ceftaroline per CAMERA-2 / ID guidance).

  • 600 mg · q8h · IV

    Off-label for refractory MRSA bacteremia — adjunct or salvage.

**Complicated SAB: 4–6 weeks** (endocarditis, persistent bacteremia >3 days, deep-seated focus, septic shock)ID consult. Source control (line removal, abscess drainage) critical. TTE/TEE workup.

4. Directed Therapy

Always consult ID (mortality benefit).

Workup every SAB:

  • Repeat blood cultures q48h until clear (clearance day = day 1 of duration count)
  • Echocardiogram (TTE → TEE if any complicated feature: persistent bacteremia >3 d, prosthetic material, IVDU, vertebral pain, fever past 72 h)
  • Source control (line removal, drain abscess, surgical debridement)
  • Evaluate for metastatic foci: back pain → MRI spine; joint pain → aspirate; new murmur → echo

MSSA → narrow to cefazolin (preferred over nafcillin: less hepatotoxicity, q8h dosing, equal or superior efficacy in observational data).

MRSA persistent bacteremia (>3–5 days): consider source control failure, vancomycin failure (high MIC or hVISA), endocarditis. Options: switch to daptomycin ± β-lactam combo (cefazolin or ceftaroline per CAMERA-2 guidance).

5. Monitoring

Daily: repeat blood cultures, exam for new murmur / joint findings / back pain / abscess. Vanco AUC + Cr. Daptomycin weekly CK. Procalcitonin trend.

Echo timing: TEE within 5–7 days of bacteremia clearance for endocarditis exclusion if any complicated feature.

Duration starts from first negative blood culture. Failed clearance at 5 days → re-evaluate source control.

Pearls

S. aureus is never a contaminant. MSSA → cefazolin > vancomycin (mortality difference). All SAB needs ID consult (proven mortality benefit). MRSA nasal PCR doesn't help here — we already know S. aureus is in the blood. Persistent SAB → think failed source control / endocarditis / vertebral osteomyelitis / epidural abscess.

References